Cancer Updates
Cancer news from the American Cancer Society.
Filtering by:
TreatmentFDA Approves First Drug for Cancers with a High Tumor Mutational Burden
Published on: June 18, 2020
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug pembrolizumab (Keytruda) to include any cancer with a high tumor mutational burden (TMB-H).
Medicare Expands Telehealth to Help Seniors Stay Home
Published on: March 19, 2020
Medicare has changed its policies to make it easier for older Americans to “see” their doctors without going in for an office visit, using their home computer or other device.
FDA Approves Ayvakit (Avapritinib) for GIST
Published on: January 10, 2020
The US Food and Drug Administration (FDA) has approved Ayvakit (avapritinib) to treat people with advanced cases of gastrointestinal stromal tumor (GIST) that have a certain genetic mutation.
FDA Approves Padcev (Enfortumab vedotin-ejfv) for Bladder Cancer
Published on: December 20, 2019
The US Food and Drug Administration (FDA) has approved a new type of drug for certain people with bladder cancer.
Study: Hormone Treatment for Prostate Cancer Linked With Dementia
Published on: July 30, 2019
Researchers from the University of Pennsylvania found that older prostate cancer patients getting hormone treatment, called androgen deprivation therapy (ADT), were more likely to be diagnosed later with Alzheimer’s disease or dementia.